Magnetic resonance imaging and ultrasound evaluation after breast autologous fat grafting combined with platelet-rich plasma.

Plastic and reconstructive surgery 2013 Vol.132(4) p. 498e-509e

Fiaschetti V, Pistolese CA, Fornari M, Liberto V, Cama V, Gentile P, Floris M, Floris R, Cervelli V, Simonetti G

관련 도메인

Abstract

[BACKGROUND] Breast lipofilling is a fairly simple and safe procedure if it is performed by experienced surgeons.

[METHODS] The authors evaluated the radiologic findings from 24 breasts (15 women) subjected to a lipofilling procedure (two sessions) for corrective surgery or cosmetic reasons. Mammography, ultrasound, and magnetic resonance imaging were performed before the first lipofilling session (T0) and 12 months after the last session (T12); ultrasound and magnetic resonance imaging were used 3 months after the first session (Ti) and 3 and 6 months after the last session (T3 and T6). Volumetric evaluations were also made through three-dimensional magnetic resonance imaging reconstruction.

[RESULTS] Ultrasound showed oily cysts in 66.67 percent of the breasts at Ti, 70.83 percent at T3, 62.5 percent at T6, and 45.83 percent at T12, whereas magnetic resonance imaging detected oily cysts in 8.33 percent at Ti and T3 and T6 months and 4.17 percent at T12. At Ti, T3, and T6, the cytosteatonecrotic areas identified on both ultrasound and magnetic resonance imaging were unchanged (8.33 percent), whereas at T12 those cytosteatonecrotic areas were increased on ultrasound (12.5 percent) and even more on the magnetic resonance imaging scans (16.67 percent). The average resorption percentage of injected volume was 15.36 percent at T6 months and 28.23 percent at T12 months.

[CONCLUSIONS] Postlipofilling breast changes can be distinguished from malignant alterations by experienced radiologists and need not interfere with early cancer diagnosis if patients are checked regularly. Moreover, magnetic resonance imaging is very useful for breast volume assessments and for detecting possible changes during longitudinal study.

[CLINICAL QUESTION/LEVEL OF EVIDENCE] Therapeutic, IV.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
해부 breast 유방 dict 4
해부 fat scispacy 1
해부 platelet-rich plasma scispacy 1
해부 T12 scispacy 1
해부 breasts scispacy 1
약물 platelet-rich C0370220
Platelet rich plasma
scispacy 1
약물 [BACKGROUND] Breast lipofilling scispacy 1
약물 [CONCLUSIONS] scispacy 1
질환 breasts C0006141
Breast
scispacy 1
질환 cancer C0006826
Malignant Neoplasms
scispacy 1
기타 women scispacy 1
기타 Ti, 70.83 percent at scispacy 1
기타 patients scispacy 1

MeSH Terms

Adipose Tissue; Adult; Aged; Breast; Combined Modality Therapy; Cysts; Female; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Mammaplasty; Mammography; Middle Aged; Necrosis; Platelet-Rich Plasma; Postoperative Complications; Surgery, Plastic; Transplantation, Autologous; Treatment Outcome; Ultrasonography, Mammary; Young Adult

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문